Potencjalne niedodiagnozowanie współchorobowości somatycznej u pacjentów chorych na schizofrenię i zaburzenia afektywne dwubiegunowe

© Borgis - Medycyna Rodzinna 3/2020, s. 99-108 | DOI: 10.25121/MR.2020.23.3.99

Michał Krzysztof Ring¹, Dominika Berent¹, Przemysław Bieńkowski²

Summary
Introduction. Patients treated for schizophrenia and for bipolar affective disorder have a potentially higher risk of developing chronic somatic diseases compared to the general population.
Aim. This is to compare the prevalence of somatic co-morbidity in patients with schizophrenia, patients with bipolar affective disorder (BD) and available data on the prevalence of somatic diseases in the general Polish population.
Material and methods. Archival data of 527 (F = 249) patients with a diagnosis of schizophrenia, aged 42.56 ± 14.25 (M ± SD), and 155 (F = 82) patients with BD, aged 48.05 ± 14.45 (M ± SD), hospitalized in psychiatric hospital in Central Poland in 2019 were analyzed.
Results. Majority of patients with schizophrenia and with BD had no registered somatic co-morbidity (80.6 and 67.7%, respectively); most common group of coexisting somatic diseases in both subgroups of patients were diseases of circulatory system (11.0 and 22.6%, respectively); and the most common disease was primary hypertension (10.4 and 20.6%, respectively). In men in the 7^th decade of life, diseases of the circulatory system were significantly more common in patients with BD than in those with schizophrenia (p = 0.004). The prevalence of somatic diseases in both subgroups of patients turned out to be lower than their prevalence in the general population.
Conclusions. Somatic co-morbidity in patients with BP and with schizophrenia is potentially underdiagnosed. Possible reasons of this finding were carefully discussed.

To jest tylko fragment artykułu. Aby przeczytać całość, przejdź do Czytelni medycznej.